Stockscreener 앱 받기
37.40
3.03%
-1.17
전일 마감가:
$38.57
열려 있는:
$38.74
하루 거래량:
419.68K
Relative Volume:
0.68
시가총액:
$1.89B
수익:
$249.12M
순이익/손실:
$7.11M
주가수익비율:
300.16
EPS:
0.1246
순현금흐름:
$-8.30M
1주 성능:
-3.01%
1개월 성능:
+5.35%
6개월 성능:
+0.75%
1년 성능:
-33.63%
1일 변동 폭
$37.36
$39.07
1주일 범위
$35.99
$39.07
52주 변동 폭
$29.24
$63.00
베리셀 Stock (VCEL) Company Profile
명칭
Vericel Corp
전화
(734) 930-5555
주소
64 SIDNEY ST., CAMBRIDGE, MA
VCEL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
37.40 | 1.95B | 249.12M | 7.11M | -8.30M | 0.1246 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
베리셀 Stock (VCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-08-09 | 개시 | Canaccord Genuity | Buy |
| 2024-06-20 | 개시 | TD Cowen | Buy |
| 2024-01-25 | 업그레이드 | Truist | Hold → Buy |
| 2023-08-08 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-11-09 | 다운그레이드 | Truist | Buy → Hold |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2021-01-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 개시 | Stephens | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2019-10-09 | 개시 | H.C. Wainwright | Buy |
| 2019-02-28 | 다운그레이드 | Needham | Buy → Hold |
| 2018-08-08 | 재확인 | Needham | Buy |
| 2018-07-16 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | 개시 | Leerink Partners | Outperform |
| 2018-03-06 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | 재확인 | Needham | Buy |
| 2018-03-05 | 재확인 | BTIG Research | Buy |
| 2017-06-21 | 개시 | BTIG Research | Buy |
| 2017-03-13 | 재확인 | Needham | Buy |
| 2016-12-22 | 개시 | Piper Jaffray | Overweight |
| 2016-11-09 | 재확인 | Needham | Buy |
| 2016-04-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | 업그레이드 | Needham | Hold → Buy |
모두보기
베리셀 주식(VCEL)의 최신 뉴스
Vericel Corporation (NASDAQ:VCEL) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Vericel (NASDAQ:VCEL) Stock Rating Lowered by Wall Street Zen - Defense World
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Debt-Free Balance Sheet, MACI Momentum, And Burn Care Portfolio Put Vericel On Investors' Radar - RTTNews
Why Is Vericel Stock Gaining Tuesday? - Benzinga
Vericel reports preliminary 2025 revenue of $276 million By Investing.com - Investing.com Canada
Vericel reports preliminary 2025 revenue of $276 million - Investing.com
Vericel Corporation Anticipates $276 Million Total Revenue and 23% Growth in Fourth Quarter Results - Quiver Quantitative
Vericel (NASDAQ: VCEL) shares preliminary 2025 results, updates outlook - Stock Titan
Vericel Announces Preliminary 2025 Financial Results and Business Updates - Yahoo Finance
Vericel Corporation (VCEL) Stock Analysis: Unveiling A 50% Upside In The Biotech Sector - DirectorsTalk Interviews
Vericel Corporation $VCEL Shares Sold by Conestoga Capital Advisors LLC - Defense World
How institutional buying supports Vericel Corporation stockJuly 2025 Review & Risk Managed Investment Entry Signals - Улправда
Bond Watch: Why analysts upgrade Vericel Corporation stockFed Meeting & Free Long-Term Investment Growth Plans - Улправда
Why analysts upgrade Vericel Corporation stockCPI Data & Short-Term Trading Opportunity Alerts - Улправда
Shares soar in Vericel after trial shows ixmyelocel-T reduces cardiac events - The Pharma Letter
Vericel Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 - Quiver Quantitative
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 - Yahoo Finance
VCEL Crosses Above Key Moving Average Level - Nasdaq
Vericel: Growth Plans May Have Run Out Of Gas (Rating Downgrade) - Seeking Alpha
Vericel (NASDAQ:VCEL) Share Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
Vericel (VCEL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Vericel Corporation (NASDAQ:VCEL) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Will Vericel Corporation (ATQP) stock sustain uptrend momentumStock Watchlist Updates & Free Trading Signals to Sharpen Your Edge - bollywoodhelpline.com
How Investors Are Reacting To Vericel (VCEL) Reaffirmed Guidance And MACI-Focused Growth Narrative - simplywall.st
Truist Slashes PT on Vericel Corporation (VCEL) to $45 From $50 - Insider Monkey
Congress Asset Management Co. Lowers Stake in Vericel Corporation $VCEL - MarketBeat
Vericel price target lowered to $45 from $50 at Truist - MSN
VCEL (Vericel) EV-to-OCF : 30.39 (As of Dec. 19, 2025) - GuruFocus
How Vericel Corporation stock reacts to inflationary pressures2025 Valuation Update & Weekly Market Pulse Updates - DonanımHaber
Why Vericel Corporation stock could see breakout soonMarket Volume Report & Long-Term Safe Investment Plans - DonanımHaber
Vericel (VCEL) Sees Target Price Lowered by Truist Securities | - GuruFocus
VCEL FinancialsIncome Statement - Quiver Quantitative
Here's Why We Think Vericel (NASDAQ:VCEL) Might Deserve Your Attention Today - Yahoo Finance
Institutional Investors Accumulate Vericel Shares Amid Positive Earnings Shift - AD HOC NEWS
Vericel Corp (VCEL) CHRO receives 2,625 shares from RSU vesting on 07/22/2025 - Stock Titan
Osterweis Capital Management Inc. Takes $9.71 Million Position in Vericel Corporation $VCEL - MarketBeat
Next Century Growth Investors LLC Has $28.45 Million Stock Position in Vericel Corporation $VCEL - MarketBeat
How Vericel’s Q3 Beat and MACI Arthro Momentum Could Shape Vericel (VCEL) Investors’ Outlook - simplywall.st
Russell Investments Group Ltd. Purchases 32,976 Shares of Vericel Corporation $VCEL - MarketBeat
Is Vericel’s Recent Pullback a Chance or a Warning for Investors in 2025? - simplywall.st
Vericel (VCEL) director Wotton sells $189500 in stock - Investing.com India
Director’s Big Move: Vericel Stock Sale Shakes Up the Market! - TipRanks
Insider Sell: Paul Wotton Sells 5,000 Shares of Vericel Corp (VC - GuruFocus
Vericel’s chief medical officer sells $64,659 in VCEL stock By Investing.com - Investing.com South Africa
Vericel (VCEL) director Wotton sells $189500 in stock By Investing.com - Investing.com South Africa
Vericel’s chief medical officer sells $64,659 in VCEL stock - Investing.com India
Vericel Corp Executives Sell Shares - TradingView
Vericel Corp (VCEL) expanding its growth trajectory ahead - Setenews
How strong is Vericel Corporation stock revenue growthEarnings Trend Report & Daily Growth Stock Tips - Newser
Vericel Corporation (VCEL) Stock Forecasts - Yahoo Finance
베리셀 (VCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):